[Anemia as a risk factor of contrast-associated acute kidney injury]

O I Mironova1, A D Deev2, P G Lakotka1

  • 1Sechenov First Moscow State Medical University (Sechenov University).

Insights

Anemia may increase the risk of contrast-associated acute kidney injury (CA-AKI) in patients with coronary artery disease. However, this study did not find a statistically significant link, suggesting further research is needed.

Area of Science:

  • Nephrology
  • Cardiology
  • Hematology

Background:

  • Contrast-associated acute kidney injury (CA-AKI) is a significant concern in patients undergoing procedures involving contrast media.
  • Anemia is a common comorbidity in patients with coronary artery disease (CAD).
  • The potential role of anemia as a risk factor for CA-AKI requires further investigation.

Purpose of the Study:

  • To evaluate the association between anemia and the incidence of CA-AKI in patients with stable coronary artery disease.
  • To determine if anemia is an independent risk factor for developing CA-AKI post-contrast administration.

Main Methods:

  • A prospective cohort study including 1023 patients with chronic coronary artery disease.
  • Anemia was present in 83 patients.
  • CA-AKI was defined by KDIGO criteria (≥25% or ≥0.5 mg/dl increase in serum creatinine within 48 hours post-contrast).

Main Results:

  • CA-AKI developed in 14.5% of patients with anemia based on relative creatinine increase.
  • CA-AKI prevalence was 2.4% based on absolute creatinine increase in anemic patients.
  • While the rate of CA-AKI was higher in anemic patients (14.4% vs. 12.7%), the difference was not statistically significant (p=0.61).

Conclusions:

  • The study observed a higher prevalence of CA-AKI in patients with anemia, but this finding did not reach statistical significance.
  • Further research with larger cohorts is warranted to definitively establish the role of anemia in CA-AKI development.
Abstract

Related Concept Videos

Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
130
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
514
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
259
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
444
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
405
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
118